INSTITUTO UNIVERSITARIO DE INTEGRACIÓN EN LA COMUNIDAD
Instituto
Sociedad Española de Reumatología
Madrid, EspañaPublicacións en colaboración con investigadores/as de Sociedad Española de Reumatología (10)
2021
-
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
Clinical Rheumatology, Vol. 40, Núm. 10, pp. 3979-3988
2019
-
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
Rheumatology International, Vol. 39, Núm. 3, pp. 509-515
-
Objectives and methodology of BIOBADASER phase III
Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236
-
SER recommendations on the use of biological drugs in primary Sjögren's syndrome
Reumatologia Clinica, Vol. 15, Núm. 6, pp. 315-326
2017
-
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort
Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942
2016
-
Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort
Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580
2012
-
Prevalence and risk factors for non-vertebral fractures in patients receiving oral glucocorticoids
International Journal of Endocrinology and Metabolism, Vol. 10, Núm. 2, pp. 480-485
2011
-
Actualización 2011 del consenso Sociedad Española de Reumatología de osteoporosis
Reumatologia Clinica, Vol. 7, Núm. 6, pp. 357-379
2009
-
Characteristics of Paget's disease in Spain. Data from the National Paget's Register
Reumatologia Clinica, Vol. 5, Núm. 3, pp. 109-114
2008
-
Prevalence of Paget's disease of bone in Spain
Bone, Vol. 43, Núm. 6, pp. 1006-1009